Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06380179 · ClinicalTrials.gov registry record · NA
Photomedicine Project 14: PBMT for Performance Enhancement in SOF
A NA study of Performance Enhancement and Photobiomodulation Therapy, sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR).
- Recruiting
- Registry status
- NA
- Development phase
- 116
- Enrollment target
- 1
- Study location
NCT06380179 is a NA study of Performance Enhancement and Photobiomodulation Therapy that is actively recruiting participants, run by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR). The registered enrollment target is 116 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06380179, a NA study of Performance Enhancement and Photobiomodulation Therapy, is actively recruiting participants, sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR).
- RECRUITING
- Registry status
- NA
- Development phase
- 116 participants
- Enrollment target
- 1
- Study location
Study Summary
Special Operations Forces (SOF) train continually to maintain peak performance. Thus, they are nearly always in a state of recovery, and in need of noninvasive therapies to address the taxing workload. Photobiomodulation therapy (PBMT) is a noninvasive treatment where a low-level laser is applied to the body to enhance healing, recovery, and performance. Army Tactical Human Optimization Rapid Rehabilitation and Reconditioning (THOR3) provides a consistent avenue for implementation of PBMT as a modality. Studies in athletes have shown performance and recovery benefits with pre-and post-workout focal application of PBMT. While there is less evidence on the potential cognitive/behavioral effects of a systematic application of PBMT, self-reported fatigue has also been found to be significantly lower in groups with focal PBMT application as compared to placebo. Further, PBMT research in healthy military tactical athletes is limited. PBMT may be a promising tool for enhancing physical performance by accelerating musculoskeletal and psychological recovery in the SOF population. The investigators aim to study the physiologic and behavioral effects of PBMT application post-exercise on performance in SOF Operators. The Intent: The investigators propose to conduct a single-blinded randomized-control trial with sham control to investigate the effectiveness of providing PBMT post physical training in a SOF population. The specific aims of this study are to: 1. Analyze and describe the physiologic effects, if any, of PBMT application post-exercise in Special Forces Operators undergoing coach-led training. 2. Analyze and describe the behavioral effects, if any, of PBMT application post-exercise in Special Forces Operators undergoing coach-led training. 3. Evaluate the overall clinical utility of focal PBMT subsequent to physical training in a US Army SOF, tactical athlete population.
Conditions Studied
Interventions
- DEVICE THOR3 training + Photobiomodulation Therapy (PBMT)
- DEVICE THOR3 training + sham PBMT
Study Locations (1)
Washington
- Joint Base Lewis-McChord - Joint Base Lewis McChord
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2025-01-23 |
| Est. Completion | 2025-12 |
| Phase | NA |
Sponsor
Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR)1 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06380179
The ClinicalTrials.gov registry entry for NCT06380179 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), which has 1 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Performance Enhancement appearing as the primary indexed condition, and to 2 interventions - of which THOR3 training + Photobiomodulation Therapy (PBMT) is the first listed.
NCT06380179 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT06380179 about?
NCT06380179 is a clinical study titled "Photomedicine Project 14: PBMT for Performance Enhancement in SOF". Special Operations Forces (SOF) train continually to maintain peak performance. Thus, they are nearly always in a state of recovery, and in need of noninvasive therapies to address the taxing workload. Photobiomodulation therapy (PBMT) is a noninvasive treatment where a low-level laser is applied to...
What is the current status of trial NCT06380179?
This trial is currently recruiting. It is a NA study. The enrollment target is 116 participants. The study started on 2025-01-23. Estimated completion is 2025-12.
What conditions does trial NCT06380179 study?
This clinical trial studies the following conditions: Performance Enhancement, Photobiomodulation Therapy, Photomedicine, Low-Level Laser Therapy, Quadriceps.
What interventions are being tested in trial NCT06380179?
The interventions under investigation include: THOR3 training + Photobiomodulation Therapy (PBMT) (DEVICE), THOR3 training + sham PBMT (DEVICE).
Who is sponsoring clinical trial NCT06380179?
This trial is sponsored by Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR), which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06380179 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Performance Enhancement
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.